3.6 OSTEOPROTEGERIN IS ASSOCIATED INDEPENDENTLY WITH AORTIC STIFFNESS IN PATIENTS WITH ATHEROSCLEROSIS AND IN HEALTHY SUBJECTS

Background: Arterial stiffening is an independent predictor for cardiovascular mortality. Preliminary studies have shown that arterial calcification may have impact on increased vascular stiffness. However, little is known about the role of calcification inhibitor osteoprotegerin (OPG) as an indepen...

Full description

Bibliographic Details
Main Authors: M. Zagura, M. Sergejev, J. Lieberg, P. Kampus, A. Peetsalu, J. Eha, M. Zilmer, J. Kals
Format: Article
Language:English
Published: BMC 2009-12-01
Series:Artery Research
Online Access:https://www.atlantis-press.com/article/125927347/view
_version_ 1811300856112349184
author M. Zagura
M. Sergejev
J. Lieberg
P. Kampus
A. Peetsalu
J. Eha
M. Zilmer
J. Kals
author_facet M. Zagura
M. Sergejev
J. Lieberg
P. Kampus
A. Peetsalu
J. Eha
M. Zilmer
J. Kals
author_sort M. Zagura
collection DOAJ
description Background: Arterial stiffening is an independent predictor for cardiovascular mortality. Preliminary studies have shown that arterial calcification may have impact on increased vascular stiffness. However, little is known about the role of calcification inhibitor osteoprotegerin (OPG) as an independent predictor of arterial stiffness in patients with peripheral arterial disease (PAD) and in healthy subjects. Aim: To evaluate the association between OPG level and arterial stiffness parameters in patients with PAD and in healthy subjects. Materials and methods: We studied 59 males with PAD (age 63±7 years) and 44 healthy subjects (age 54±7 years). Serum OPG level was measured using ELISA kit. Arterial stiffness parameters, such as aortic pulse wave velocity aPWV and augmentation index, were determined by applanation tonometry using the Sphygmocor device. Results: OPG level (5.40±1.77 vs 4.19±1.14 (pmol/L); p<0.001) and aPWV (9.86±2.31 vs 7.69±1.66 (m/s); p<0.001) were different for the patients and for the controls. There was linear relationship between OPG level and aPWV in patients with PAD (R=0.51, p=0.0001) as well as in healthy individuals (R=0.47; p=0.002). In multiple regression models, OPG level was independently associated with aPWV along with age and mean arterial pressure in the patient group (R2=0.34; p=0.034) as well as in the controls (R2=0.49; p=0.037) Conclusion: The independent association between OPG level and aPWV in patients with PAD and in controls suggests that calcification inhibitor OPG may be important in the process of aortic stiffening in atherosclerosis and in healthy subjects.
first_indexed 2024-04-13T06:58:40Z
format Article
id doaj.art-2c65bd7002784a6b86d3012c123846dc
institution Directory Open Access Journal
issn 1876-4401
language English
last_indexed 2024-04-13T06:58:40Z
publishDate 2009-12-01
publisher BMC
record_format Article
series Artery Research
spelling doaj.art-2c65bd7002784a6b86d3012c123846dc2022-12-22T02:57:11ZengBMCArtery Research1876-44012009-12-013410.1016/j.artres.2009.10.1573.6 OSTEOPROTEGERIN IS ASSOCIATED INDEPENDENTLY WITH AORTIC STIFFNESS IN PATIENTS WITH ATHEROSCLEROSIS AND IN HEALTHY SUBJECTSM. ZaguraM. SergejevJ. LiebergP. KampusA. PeetsaluJ. EhaM. ZilmerJ. KalsBackground: Arterial stiffening is an independent predictor for cardiovascular mortality. Preliminary studies have shown that arterial calcification may have impact on increased vascular stiffness. However, little is known about the role of calcification inhibitor osteoprotegerin (OPG) as an independent predictor of arterial stiffness in patients with peripheral arterial disease (PAD) and in healthy subjects. Aim: To evaluate the association between OPG level and arterial stiffness parameters in patients with PAD and in healthy subjects. Materials and methods: We studied 59 males with PAD (age 63±7 years) and 44 healthy subjects (age 54±7 years). Serum OPG level was measured using ELISA kit. Arterial stiffness parameters, such as aortic pulse wave velocity aPWV and augmentation index, were determined by applanation tonometry using the Sphygmocor device. Results: OPG level (5.40±1.77 vs 4.19±1.14 (pmol/L); p<0.001) and aPWV (9.86±2.31 vs 7.69±1.66 (m/s); p<0.001) were different for the patients and for the controls. There was linear relationship between OPG level and aPWV in patients with PAD (R=0.51, p=0.0001) as well as in healthy individuals (R=0.47; p=0.002). In multiple regression models, OPG level was independently associated with aPWV along with age and mean arterial pressure in the patient group (R2=0.34; p=0.034) as well as in the controls (R2=0.49; p=0.037) Conclusion: The independent association between OPG level and aPWV in patients with PAD and in controls suggests that calcification inhibitor OPG may be important in the process of aortic stiffening in atherosclerosis and in healthy subjects.https://www.atlantis-press.com/article/125927347/view
spellingShingle M. Zagura
M. Sergejev
J. Lieberg
P. Kampus
A. Peetsalu
J. Eha
M. Zilmer
J. Kals
3.6 OSTEOPROTEGERIN IS ASSOCIATED INDEPENDENTLY WITH AORTIC STIFFNESS IN PATIENTS WITH ATHEROSCLEROSIS AND IN HEALTHY SUBJECTS
Artery Research
title 3.6 OSTEOPROTEGERIN IS ASSOCIATED INDEPENDENTLY WITH AORTIC STIFFNESS IN PATIENTS WITH ATHEROSCLEROSIS AND IN HEALTHY SUBJECTS
title_full 3.6 OSTEOPROTEGERIN IS ASSOCIATED INDEPENDENTLY WITH AORTIC STIFFNESS IN PATIENTS WITH ATHEROSCLEROSIS AND IN HEALTHY SUBJECTS
title_fullStr 3.6 OSTEOPROTEGERIN IS ASSOCIATED INDEPENDENTLY WITH AORTIC STIFFNESS IN PATIENTS WITH ATHEROSCLEROSIS AND IN HEALTHY SUBJECTS
title_full_unstemmed 3.6 OSTEOPROTEGERIN IS ASSOCIATED INDEPENDENTLY WITH AORTIC STIFFNESS IN PATIENTS WITH ATHEROSCLEROSIS AND IN HEALTHY SUBJECTS
title_short 3.6 OSTEOPROTEGERIN IS ASSOCIATED INDEPENDENTLY WITH AORTIC STIFFNESS IN PATIENTS WITH ATHEROSCLEROSIS AND IN HEALTHY SUBJECTS
title_sort 3 6 osteoprotegerin is associated independently with aortic stiffness in patients with atherosclerosis and in healthy subjects
url https://www.atlantis-press.com/article/125927347/view
work_keys_str_mv AT mzagura 36osteoprotegerinisassociatedindependentlywithaorticstiffnessinpatientswithatherosclerosisandinhealthysubjects
AT msergejev 36osteoprotegerinisassociatedindependentlywithaorticstiffnessinpatientswithatherosclerosisandinhealthysubjects
AT jlieberg 36osteoprotegerinisassociatedindependentlywithaorticstiffnessinpatientswithatherosclerosisandinhealthysubjects
AT pkampus 36osteoprotegerinisassociatedindependentlywithaorticstiffnessinpatientswithatherosclerosisandinhealthysubjects
AT apeetsalu 36osteoprotegerinisassociatedindependentlywithaorticstiffnessinpatientswithatherosclerosisandinhealthysubjects
AT jeha 36osteoprotegerinisassociatedindependentlywithaorticstiffnessinpatientswithatherosclerosisandinhealthysubjects
AT mzilmer 36osteoprotegerinisassociatedindependentlywithaorticstiffnessinpatientswithatherosclerosisandinhealthysubjects
AT jkals 36osteoprotegerinisassociatedindependentlywithaorticstiffnessinpatientswithatherosclerosisandinhealthysubjects